Sangamo Biosciences, Inc.
NASDAQ: SGMO
$3.95
Closing price May 17, 2022
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Baker Hughes, Brocade Communications, CenturyLink, Chevron, Juniper Networks and National Oilwell Varco.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apollo Global, ADM, Celgene, Total, Whole Foods and Targa Resources.
5 years ago
Last Updated: 2 years ago
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs to the clinic this year.
6 years ago
Last Updated: 2 years ago
Stocks tried to stabilize on Monday, and Tuesday’s early indications were for Dow and S&P 500 futures to be up almost 1%. Last week’s sell-off may have been the worst opening week for...
6 years ago
Last Updated: 2 years ago
These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks, even if many of these are large cap stocks.
6 years ago
Last Updated: 2 years ago
Thursday’s top analyst upgrades, downgrades and initiations include AK Steel, CVS Health, Micron Technology, Nike, Oracle, Pandora Media, Sunrun and US Steel.
6 years ago
Last Updated: 2 years ago
Investors and traders alike always seem to be on the lookout for new investment ideas. With the S&P 500 and the Dow Jones Industrial Average having recently hit new highs, 24/7 Wall St. decided...
9 years ago
Last Updated: 2 years ago
The three major US stock indexes opened higher this morning, following on a positive debt sale by Portugal and some improvement in PMI numbers from Europe. ADP employment data did not meet...
10 years ago
Last Updated: 2 years ago
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Alcatel-Lucent (NYSE: ALU), US Airways Group, LLC. (NYSE:...
10 years ago
Last Updated: 10 years ago
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ: CEPH) in a $6.8 billion...
11 years ago
Last Updated: 11 years ago
We are seeing more and more waves of secondary offerings continue to hit the Street since the stock market has held up. Many stocks are close to near-term highs and it seems they are raising cash in...
12 years ago
Last Updated: 2 years ago
These are some of the top pre-market analyst upgrades and positive calls from Wall Street this Thursday morning: AEterna Zentaris (AEZS) Raised to Outperform at RBC. Akamai Tech (AKAM) Raised to Buy...
13 years ago
Last Updated: 2 years ago
Focus Media (FMCN) is getting crushed this morning after posted bad numbers. Details..Sangamo Biosciences (SGMO) ran into drug trial troubles and will trade way down. Optimer Pharmaceuticals (OPTR)...
13 years ago
Last Updated: 2 years ago
Get Our Free Investment Newsletter